Replies to post #435478 on Anavex Life Sciences Corp (AVXL)

[ignatiusrielly35]

Agreed. He is astute enough to know the difference between insufficient proof of efficacy and a company misrepresenting that endpoints were met. The Aldeyra situation is just an unapproved application, which is not exactly a rare outcome.